Introduction / Definition

Charcot neuroarthropathy (CNA), or neuropathic osteoarthropathy, is a non-infectious, progressive destructive process affecting bone architecture and articular structures in patients with sensory peripheral neuropathy. Historically described by Jean-Martin Charcot in 1868 in the context of tabes dorsalis from tertiary syphilis, its predominant contemporary aetiology in high-income nations is diabetic peripheral neuropathy. If left unmanaged, the cascade of microvascular dysregulation, osteoclastic hyper-resorption, and repetitive unperceived mechanical loading leads to pathological fractures, multi-articular dislocations, classic 'rocker-bottom' collapse, secondary cutaneous ulceration, osteomyelitis, and amputation.

Epidemiology & Pathophysiology

Epidemiology

• Prevalence: CNA affects approximately 0.1% to 7.5% of the overall diabetic population, increasing to up to 29% in those with documented dense sensory neuropathy.
• Demographics: Typically presents in the fifth to sixth decades of life with long-standing type 1 or poorly controlled type 2 diabetes mellitus.
• Bilateral Involvement: Approximately 9% to 35% of patients develop bilateral disease, either concurrently or sequentially.
• Other Causes: Chronic alcohol abuse, syringomyelia (frequently affecting the upper limb / shoulder), leprosy (Hansen disease), vitamin B12 deficiency, spinal cord injury, and tabes dorsalis.

Pathophysiology

Two complementary historical theories underpin modern molecular understanding:

1. Neurotraumatic (German) Theory (Virchow / Volkmann): Loss of protective pain sensation and proprioception permits repetitive, unperceived mechanical microtrauma, culminating in unrecognised trabecular microfractures, joint incongruity, and ligamentous disruption.
2. Neurovascular (French) Theory (Charcot): Autonomic neuropathy produces sympathetic denervation, leading to persistent peripheral hyperaemia and arteriovenous shunting. This washes out bone minerals, yielding profound osteopenia.
3. Modern Unified Cytokine Model: Autonomic dysregulation and microtrauma drive unabated local production of pro-inflammatory cytokines (tumour necrosis factor-alpha [TNF-α], interleukin-1 beta [IL-1β], and IL-6). This stimulates the receptor activator of nuclear factor-κB ligand (RANKL) pathway, overpowering osteoprotegerin (OPG). The resulting osteoclastogenesis dramatically outpaces osteoblastic bone synthesis, triggering rapid bone demineralisation, fragmentation, and architectural collapse.

Relevant Anatomy

The foot and ankle are the primary sites involved, anatomically broken down into functional zones (adapted in the Brodsky and Trepman classifications):

• Tarsometatarsal (Lisfranc) & Naviculocuneiform Joints: Most vulnerable to axial and bending collapse, leading to lateral subluxation, loss of the medial longitudinal arch, and midfoot plantar prominence.
• Chopart (Talonavicular & Calcaneocuboid) and Subtalar Joints: Subject to hindfoot varus or valgus collapse, causing marked joint instability and severe dynamic malalignment.
• Tibiotalar (Ankle) Joint: Exhibits significant instability; collapse here frequently yields ulceration directly over the malleoli and carries the highest risk of major lower-extremity amputation.
• Posterior Calcaneal Tuberosity: Avulsion fracture due to unopposed Achilles tendon pull, producing complete loss of the calcaneal pitch angle.

Classification Systems

Eichenholtz Classification (Temporal / Radiographic Staging)

• Stage 0 (Prodromal / Active Pre-radiographic; added by Shibata et al.): Erythema, warmth, and oedema following minor trauma; radiographs are normal, but MRI demonstrates diffuse marrow oedema, microfractures, and joint effusion.
• Stage 1 (Development / Fragmentation): Capsular distension, bony fragmentation, periarticular subluxations, dislocations, and debris formation on plain radiographs. Marked clinical erythema and oedema.
• Stage 2 (Coalescence): Absorption of fine bony debris, bridging trabeculae, coalescence of larger fragments, and early periosteal new bone formation. Clinical warmth and swelling subside.
• Stage 3 (Reconstruction / Consolidation): Joint consolidation, arthrosis, osteophyte formation, and cortical rounding. The inflammatory response has resolved; the foot is cool and stable, but often fixed in substantial anatomical deformity.

Brodsky Classification (Anatomic Location)

• Type 1 (60%): Midfoot (tarsometatarsal and naviculocuneiform articulations). Leads to fixed valgus rocker-bottom deformity with plantar-medial prominence.
• Type 2 (10%): Hindfoot (subtalar, talonavicular, or calcaneocuboid articulations). Prone to marked instability; requires prolonged immobilization (up to 2 years).
• Type 3A (20%): Ankle (tibiotalar joint). Unstable with rapid progression to severe varus/valgus deformity, skin breakdown over malleoli, and elevated amputation rates.
• Type 3B (<10%): Calcaneus (pathological fracture/avulsion of the posterior calcaneal tuberosity).
• Type 4 (Trepman modification, <10%): Multiple regions / concurrent multi-segmental involvement.
• Type 5 (Trepman modification, <10%): Forefoot (isolated metatarsophalangeal joints).

Clinical Presentation & Examination

History

• Sudden-onset swelling, warmth, and redness, occasionally following minor trivial trauma, sprain, or recent foot surgery.
• Pain Paradox: Pain is absent in up to 50% of presentations due to dense sensory neuropathy; the remaining 50% report mild-to-moderate discomfort disproportionately mild relative to the destructive radiographic destruction.

Physical Examination

• Inspection: Unilateral oedema, erythema, bounding pedal pulses (autonomic shunting). In late stages: classical midfoot 'rocker-bottom' contour, medial prominence of the navicular/cuneiforms, and gross hindfoot malalignment.
• Skin Temperature: Infrared dermal thermometry is indispensable. An active Charcot joint characteristically demonstrates an elevated local skin temperature >2°C compared to the contralateral corresponding site.
• Elevation Test: When the limb is elevated for 5–10 minutes, the erythema and cutaneous pooling of acute CNA resolve significantly; infectious cellulitis remains stubbornly erythematous.
• Neurological Examination: Sensation loss mapped via 10g Semmes-Weinstein monofilament and 128-Hz tuning fork. Vibration and protective sensation are typically absent.
• Ulceration & Soft Tissue Probe: Evaluate for secondary ulcers, typically located over the rocker-bottom apex (cuboid or medial cuneiform). If an ulcer is present, perform a probe-to-bone test (high positive predictive value for underlying osteomyelitis).

Investigations

Plain Radiography

• Bilateral, weight-bearing AP, lateral, and oblique views of the foot and ankle.
• Key Radiological Angles:
  • Meary angle (Talar-first metatarsal angle): Normal is 0°. Plantar apex angulation indicates breakdown of the medial column.
  • Calcaneal pitch angle: Normally 20°–30°; significantly flattened or negative in hindfoot/midfoot collapse.

Magnetic Resonance Imaging (MRI)

• Indispensable for identifying Stage 0 disease (diffuse hyperintense STIR bone marrow oedema).
• Crucial for differentiating acute Charcot from osteomyelitis. CNA shows periarticular bone oedema affecting multiple midfoot bones without discrete fluid collections; osteomyelitis displays focal geographic T1 hypointensity, cortical breach, sinus tracts, and localized subperiosteal abscess formation.

Nuclear Medicine

• Three-phase Technetium-99m bone scan is highly sensitive but non-specific (positive in all stages due to bone turnover).
• Combined In-111 labelled white cell scan (or Tc-99m HMPAO-WBC) with 99mTc-sulfur colloid marrow scan provides superior accuracy when differentiating active Charcot arthropathy from secondary osteomyelitis.

Laboratory Workup

• Baseline inflammatory markers (ESR, CRP) may be mildly elevated in active CNA but are disproportionately lower than in acute sepsis or deep closed osteomyelitis.
• HbA1c to assess glycaemic control, serum albumin, and total lymphocyte count to assess nutritional potential for wound and bone healing.

Management

Non-Operative Treatment

The gold-standard definitive therapy for acute active CNA (Stages 0, 1, and active 2) is strict non-weight-bearing immobilization until quiescent.

• Total Contact Cast (TCC):
  • Re-distributes plantar pressures evenly across the lower leg and foot, controls multi-planar shear forces, and suppresses local inflammatory osteolysis.
  • Must be changed every 1–2 weeks initially to accommodate rapid subsidence of limb oedema and prevent iatrogenic skin pressure necrosis.
  • Continued until clinical consolidation occurs (temperature difference <1°C to 2°C compared to contralateral limb on serial infrared thermometry for consecutive visits, alongside radiographic reconstitution).
• Step-Down Immobilisation:
  • Transition to a Charcot Restraint Orthotic Walker (CROW), bi-valved AFO, or custom-moulded rigid orthosis with a rocker-bottom sole once entering late Stage 2 / Stage 3.
• Pharmacotherapy:
  • Bisphosphonates (e.g. pamidronate, zoledronic acid) and RANKL inhibitors (denosumab) have been investigated to blunt osteoclastic resorption. The 2023 IWGDF guidelines explicitly advise against their routine systemic use due to lack of durable clinical improvements in bone union and fracture outcomes.

Operative Treatment

Surgery is contraindicated during active Stage 1 due to extensive osteolysis, poor bone mineralisation, and high risk of implant pull-out/failure, unless the extremity possesses gross unstable dislocation uncontrollable by casting.

Surgical Indications:

1. Severe, fixed instability unbraceable with custom orthoses.
2. Recurrent or non-healing ulcers over bony prominences failing non-operative pressure offloading.
3. Progressive, unstable hindfoot/ankle deformities with pending skin compromise.
4. Documented deep bone infection/osteomyelitis refractory to debridement.

Surgical Approaches and Techniques:

• Exostectomy (Ostectomy):
  • Resection of a prominent, plantar-directed bony beak (e.g., collapsed cuboid or medial cuneiform) causing intractable ulceration.
  • Indicated only when the midfoot and hindfoot are structurally stable and fully consolidated (Stage 3). If residual instability exists, exostectomy alone will inevitably fail.
• Achilles Tendon Lengthening (TAL):
  • Percutaneous or open Z-lengthening to relieve gastrocnemius-soleus equinus contracture, drastically reducing mechanical load across the midfoot arch.
• Midfoot Reconstruction & Arthrodesis:
  • Realignment wedge resections with internal 'superconstruct' fixation.
  • Principles of Superconstruct Fixation (Sammarco): (1) Fusion extended beyond the zone of injury; (2) Implants positioned to maximize mechanical advantage (plantar or tension-side plating); (3) Strongest possible implants utilized (e.g., large-diameter cannulated beams/screws across medial and lateral columns combined with rigid locking plates).
• Hindfoot & Ankle Arthrodesis:
  • Tibiotalocalcaneal (TTC) arthrodesis using a retrograde locked intramedullary nail or blade plate.
• Circular External Fixation (Ilizarov / Hexapod Frames):
  • Utilised for severe, multi-planar deformities, poor soft-tissue envelopes, active ulceration, or chronic infection. Facilitates gradual closed or minimally invasive multi-planar correction, rigid multi-planar cross-joint stabilization, and immediate protected axial weight-bearing without hardware spanning contaminated fields.

Complications

• Recurrent Ulceration & Osteomyelitis: Primary driver of hospital admissions and readmissions.
• Non-union & Pseudarthrosis: Hardware failure occurs in up to 30–40% of operative fusions due to poor bone quality and patient compliance.
• Infection: Deep surgical site infections and pin-site infections with external fixators.
• Major Lower Limb Amputation: Below-knee (transtibial) amputation remains an essential limb-salvage alternative for uncontrolled chronic osteomyelitis, uncorrectable deformity, or severe soft-tissue destruction.

Exam Pearls

• Temperature differential: The primary clinical metric of disease quiescence. Active CNA is defined by a >2°C skin temperature differential; cast removal and progressive weight bearing require normalization (<1°C to 2°C) for at least two consecutive monthly evaluations.
• Rule of Thumb for Surgery: In acute Stage 1, non-operative TCC is mandatory. Performing elective fusion during active Eichenholtz Stage 1 is associated with catastrophic hardware pull-out, cut-out, and failure.
• Sammarco’s Four Superconstruct Principles: (1) Extend fusion beyond injury zone; (2) Place plates on the tension side (plantar); (3) Utilize robust locked or beamed implants; (4) Minimise periosteal stripping.
• Differentiation on MRI: Osteomyelitis causes discrete focal T1 low-signal bone destruction with adjacent fluid collection/sinus tracts; Charcot arthropathy causes widespread diffuse multi-bone periarticular marrow oedema without localized abscess formation.